INS and diabetes mellitus: The American Diabetes Association (ADA) and International Society of Pediatric and Adolescent Diabetes (ISPAD) provide slightly different advice on the timing of long‐acting insulin administration in relation to the end of IV insulin infusion, with the ADA recommending a 2‐h overlap and ISPAD suggesting an overlap is acceptable without specifying the timing.18, 19